The probiotic paradox: live and dead cells are biological response modifiers
- PMID: 20403231
- DOI: 10.1017/S0954422410000090
The probiotic paradox: live and dead cells are biological response modifiers
Abstract
Probiotics are usually defined as products which contain viable non-pathogenic micro-organisms able to confer health benefits to the host. There are specific gastrointestinal effects of probiotics such as alleviating inflammatory bowel disease, reducing acute diarrhoea in children, inhibiting Salmonella and Helicobacter pylori, removing cholesterol, secreting enzymes and bacteriocins and immunomodulation. However, many of the effects obtained from viable cells of probiotics are also obtained from populations of dead cells. Heat-killed cells of Enterococcus faecalis stimulate the gastrointestinal immune system in chicks. Dead bifidobacteria induce significant increases in TNF-alpha production. Administration of heat-killed E. faecalis to healthy dogs increases neutrophil phagocytes. The probiotic paradox is that both live and dead cells in probiotic products can generate beneficial biological responses. The action of probiotics could be a dual one. Live probiotic cells influence both the gastrointestinal microflora and the immune response whilst the components of dead cells exert an anti-inflammatory response in the gastrointestinal tract. This is quite analogous to a proposed mode of action of antimicrobial growth promoters in animal production. This has several implications for the production and application of probiotics, as it will be difficult to assess the relative proportions of live and dead cells in a probiotic culture. Variable amounts of dead cells might contribute to the variation in response often seen with live probiotic cultures. However, the use of dead probiotics as biological response modifiers has several attractive advantages; such products would be very safe and have a long shelf-life.
Similar articles
-
Probiotics.Indian J Med Microbiol. 2009 Jul-Sep;27(3):202-9. doi: 10.4103/0255-0857.53201. Indian J Med Microbiol. 2009. PMID: 19584499 Review.
-
Immunology and probiotic impact of the newborn and young children intestinal microflora.Anaerobe. 2011 Dec;17(6):369-74. doi: 10.1016/j.anaerobe.2011.03.010. Epub 2011 Apr 16. Anaerobe. 2011. PMID: 21515397 Review.
-
Health-beneficial effects of probiotics: Its mode of action.Anim Sci J. 2009 Aug;80(4):361-71. doi: 10.1111/j.1740-0929.2009.00645.x. Anim Sci J. 2009. PMID: 20163595 Review.
-
Probiotics, prebiotics, and synbiotics.Adv Biochem Eng Biotechnol. 2008;111:1-66. doi: 10.1007/10_2008_097. Adv Biochem Eng Biotechnol. 2008. PMID: 18461293 Review.
-
Probiotics in inflammatory bowel disease: possible mechanisms of action.Curr Opin Gastroenterol. 2005 Jul;21(4):426-30. Curr Opin Gastroenterol. 2005. PMID: 15930982 Review.
Cited by
-
Anti-Cryptosporidial Drug-Discovery Challenges and Existing Therapeutic Avenues: A "One-Health" Concern.Life (Basel). 2024 Jan 3;14(1):80. doi: 10.3390/life14010080. Life (Basel). 2024. PMID: 38255695 Free PMC article. Review.
-
Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation.PLoS One. 2013;8(3):e59370. doi: 10.1371/journal.pone.0059370. Epub 2013 Mar 12. PLoS One. 2013. PMID: 23555025 Free PMC article.
-
An inactivated bacterium (paraprobiotic) expressing Bacillus thuringiensis Cry5B as a therapeutic for Ascaris and Parascaris spp. infections in large animals.One Health. 2021 Mar 26;12:100241. doi: 10.1016/j.onehlt.2021.100241. eCollection 2021 Jun. One Health. 2021. PMID: 33889707 Free PMC article.
-
The Neglected Microbial Components of Commercial Probiotic Formulations.Microorganisms. 2020 Aug 3;8(8):1177. doi: 10.3390/microorganisms8081177. Microorganisms. 2020. PMID: 32756409 Free PMC article.
-
Paraprobiotics strains accelerate wound repair by stimulating re-epithelialization of NIH-3T3 cells, decreasing inflammatory response and oxidative stress.Arch Microbiol. 2023 Mar 24;205(4):134. doi: 10.1007/s00203-023-03469-0. Arch Microbiol. 2023. PMID: 36959516
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical